Sanofi researches, develops, manufactures, and markets prescription drugs, vaccines, and consumer healthcare products, with focused efforts in immunology, oncology, rare diseases, and diabetes. Its Sanofi Pasteur unit is a major global vaccine producer serving public health programs and travelers. The company reaches patients and consumers through innovative therapies and established brands distributed worldwide.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 10,735 | — | 3,939 | — |
| Q3 2025 | 13,170 | — | 2,802 | — |
| Q4 2025 | 12,205 | — | -801 | — |
| Q1 2026 | 11,244 | — | 1,614 | — |
| Q2 2026 | 12,300 | 14.6% | 343 | -91.3% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Equinix, Inc. (EQIX), Constellation Energy Corporation (CEG), Adobe Inc. (ADBE), MercadoLibre, Inc. (MELI), CSX Corporation (CSX), Monster Beverage Corporation (MNST)